Our researchers | Leukaemia Foundation

All posts in Our researchers

Developing new treatments for Burkitt’s lymphoma

The Leukaemia Foundation is funding research aimed at advancing treatment for a blood cancer called Burkitt’s lymphoma (BL), thanks to the generous support of a major donor who has survived this aggressive blood cancer.  There is a need for alternative therapies for people with BL, according to Dr Gemma Kelly, a senior postdoctoral research scientist at the Walter and Eliza Hall Institute (Melbourne).  Dr Kelly and Professor […]

Working to cure and conquer every blood cancer – with care

Reshaping our thinking on blood cancer treatment

Researchers at Monash University have discovered a key reason why a type of blood cancer called acute myeloid leukaemia (AML) is such a difficult disease to treat and cure. More than 1,000 Australians are told they have AML each year but less than a third of them will be alive five years after their diagnosis. […]

Working to cure and conquer every blood cancer – with care
Dr Ken Micklethwaite

Australian study first ever to use CAR T-cells to prevent relapse after treatment

In a world first, the Australian COMMITTAL trial uses CAR T-cell therapy to improve survival for people with B-cell ALL who have an allogeneic stem cell transplantation (SCT). Dr Ken Micklethwaite, a clinical haematologist and bone marrow physician, who runs the CAR T-cell program at The Westmead Institute of Medical Research (Sydney), describes the study […]

Working to cure and conquer every blood cancer – with care

Improving lymphoma outcomes with personal touch

A recent review of the latest medical advances for people with Hodgkin lymphoma has highlighted how personalised treatment is improving outcomes for patients. Professor Maher Gandhi, the Leukaemia Foundation Chair in Blood Cancer Research at The University of Queensland’s Diamantina Institute, said the new approaches were aimed at “minimising toxicity while maximising response”. He said […]

Working to cure and conquer every blood cancer – with care

Targeting cancer ‘survival’ protein to kill cancer cells

A protein critical for the survival of many cancer cells, called MCL-1, might be the key to a new treatment for lymphoma and leukaemia patients. Leukaemia Foundation funded researcher Dr Stephanie Grabow and her team, in particular Drs Gemma Kelly and Brandon Aubrey at Melbourne’s Walter and Eliza Hall Institute of Medical Research, are investigating the […]

Working to cure and conquer every blood cancer – with care

A vital head start against cancer

Doctors will be given a valuable head start against cancer with the development of a new test that can identify the 40% of patients with an aggressive form of lymphoma who are not likely to respond to standard treatment. Our Chair in blood cancer research at UQ Diamantina Institute in Brisbane, Professor Maher Gandhi, explains the laboratory test and how […]

Working to cure and conquer every blood cancer – with care
Researcher Rebecca Austin hiking

Rising to the challenge: how I’m beating blood cancer

When she’s not hiking or rock-climbing, our researcher Rebecca Austin is pushing herself in other ways as she works to find new treatment options for leukaemia patients. This week, we announced Rebecca’s is one of several exciting new research projects we’re going to be funding. So we put her under the microscope with a few […]

Working to cure and conquer every blood cancer – with care
X
X